1. Home
  2. ALLR vs IMTE Comparison

ALLR vs IMTE Comparison

Compare ALLR & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • IMTE
  • Stock Information
  • Founded
  • ALLR 2004
  • IMTE 2008
  • Country
  • ALLR United States
  • IMTE Malaysia
  • Employees
  • ALLR N/A
  • IMTE N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • IMTE Consumer Electronics/Appliances
  • Sector
  • ALLR Health Care
  • IMTE Consumer Staples
  • Exchange
  • ALLR Nasdaq
  • IMTE Nasdaq
  • Market Cap
  • ALLR 6.0M
  • IMTE 5.3M
  • IPO Year
  • ALLR N/A
  • IMTE N/A
  • Fundamental
  • Price
  • ALLR $0.95
  • IMTE $1.26
  • Analyst Decision
  • ALLR
  • IMTE
  • Analyst Count
  • ALLR 0
  • IMTE 0
  • Target Price
  • ALLR N/A
  • IMTE N/A
  • AVG Volume (30 Days)
  • ALLR 2.3M
  • IMTE 6.4K
  • Earning Date
  • ALLR 03-07-2025
  • IMTE 03-04-2025
  • Dividend Yield
  • ALLR N/A
  • IMTE N/A
  • EPS Growth
  • ALLR N/A
  • IMTE N/A
  • EPS
  • ALLR N/A
  • IMTE N/A
  • Revenue
  • ALLR N/A
  • IMTE $123,337.00
  • Revenue This Year
  • ALLR N/A
  • IMTE N/A
  • Revenue Next Year
  • ALLR N/A
  • IMTE N/A
  • P/E Ratio
  • ALLR N/A
  • IMTE N/A
  • Revenue Growth
  • ALLR N/A
  • IMTE 4.75
  • 52 Week Low
  • ALLR $0.90
  • IMTE $1.06
  • 52 Week High
  • ALLR $264.00
  • IMTE $3.84
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 40.42
  • IMTE 47.80
  • Support Level
  • ALLR $0.91
  • IMTE $1.21
  • Resistance Level
  • ALLR $1.03
  • IMTE $1.30
  • Average True Range (ATR)
  • ALLR 0.09
  • IMTE 0.07
  • MACD
  • ALLR -0.02
  • IMTE -0.00
  • Stochastic Oscillator
  • ALLR 13.88
  • IMTE 30.16

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.

About IMTE Integrated Media Technology Limited

Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.

Share on Social Networks: